Paysign (Nasdaq:PAYS) - Stock Price, News & Analysis

PAYS Stock Overview

Provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. More details

PAYS fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	6/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 10.55% per year

Earnings grew by 420.5% over the past year

Analysts in good agreement that stock price will rise by 106.4%

Risk Analysis

Earnings are forecast to decline by an average of 24.1% per year for the next 3 years

Significant insider selling over the past 3 months

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Soaring Patient Affordability Growth Fuels Revenue But Shrinking Margins Loom

Key Takeaways Rapid growth in patient affordability programs and onboarding major pharmaceutical accounts likely to significantly boost revenue. Strategic expansion and investments in plasma centers and IT aim to improve long-term revenue and efficiency.

View narrative

US$6.81

51.6% undervalued

12.55%

Revenue growth p.a.

14 days ago

Paysign, Inc. Competitors

Cass Information Systems

NasdaqGS:CASS

US$601.0m

International Money Express

NasdaqCM:IMXI

US$651.2m

Cantaloupe

NasdaqGS:CTLP

US$653.2m

Usio

NasdaqGM:USIO

US$40.2m

Price History & Performance

Summary of all time highs, changes and price drops for Paysign
Historical stock prices
Current Share Price	US$3.30
52 Week High	US$5.59
52 Week Low	US$2.22
Beta	0.96
11 Month Change	-12.00%
3 Month Change	-29.49%
1 Year Change	41.03%
33 Year Change	64.18%
5 Year Change	-68.21%
Change since IPO	633.33%

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

Shareholder Returns

	PAYS	US Diversified Financial	US Market
7D	-10.3%	-0.04%	-1.2%
1Y	41.0%	32.4%	30.4%

Return vs Industry: PAYS exceeded the US Diversified Financial industry which returned 32.4% over the past year.

Return vs Market: PAYS exceeded the US Market which returned 30.4% over the past year.

Price Volatility

Is PAYS's price volatile compared to industry and market?
PAYS volatility
PAYS Average Weekly Movement	6.5%
Diversified Financial Industry Average Movement	5.1%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.5%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PAYS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: PAYS's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1995	123	Mark Newcomer	www.paysign.com

Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card. The company markets its prepaid card solutions under the Paysign brand.

Paysign, Inc. Fundamentals Summary

How do Paysign's earnings and revenue compare to its market cap?
PAYS fundamental statistics
Market cap	US$176.71m
Earnings (TTM)	US$8.07m
Revenue (TTM)	US$56.47m

21.9x

P/E Ratio

3.1x

P/S Ratio

Is PAYS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAYS income statement (TTM)
Revenue	US$56.47m
Cost of Revenue	US$26.33m
Gross Profit	US$30.14m
Other Expenses	US$22.07m
Earnings	US$8.07m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.15
Gross Margin	53.37%
Net Profit Margin	14.28%
Debt/Equity Ratio	0%

How did PAYS perform over the long term?

See historical performance and comparison

PAYS Stock Overview

Rewards

Risk Analysis

Soaring Patient Affordability Growth Fuels Revenue But Shrinking Margins Loom

Paysign, Inc. Competitors

NasdaqGS:CASS

US$601.0m

NasdaqCM:IMXI

US$651.2m

NasdaqGS:CTLP

US$653.2m

NasdaqGM:USIO

US$40.2m

Price History & Performance

Recent News & Updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?